NovaXS is a startup company in the field of intelligent medical devices, dedicated to improving the drug delivery process and enhancing treatment outcomes. Their core product is an intelligent needle-free drug delivery platform called Telosis. The Telosis smart needle-free injector provides a better painless patient experience and reduces administration errors and medication adherence tracking. The team has over 20 years of experience in geriatric research, accumulating extensive expertise and understanding in providing optimal preventive care solutions.
Biostage is a company focused on the field of regenerative medicine, dedicated to developing bioengineered organ implants to address organ failure and other life-threatening conditions. Biostage’s technology offers a potential solution for patients by reducing reliance on donor organs through the use of bioengineered organ implants. The founders have educational backgrounds from institutions such as Peking University, Yale University, and Case Western Reserve University, with the CEO holding an undergraduate degree from Peking University and an MBA from the University of Chicago.
JWE is dedicated to building a differentiated, globally leading, core technology-driven platform for innovative protein design and development. The company offers one-stop protein development and production technology services, including gene editing, engineering modifications, artificial intelligence optimization, protein-related product expression, analysis, screening, purification, and validation, library construction, and database construction. The founder, Dr. Wei Jiang, graduated from the University of Pennsylvania with a degree in Chemical and Biomolecular Engineering. He subsequently served as a postdoctoral fellow and lecturer at Stanford University.